{"id":"F2024L01401","name":"Medical Research Future Fund (Australian Medical Research and Innovation Priorities 2024-2026) Determination 2024","slug":"medical-research-future-fund-australian-medical-research-and-innovation-priorities-2024-2026-determi","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":105423,"registerId":"commonwealth-F2024L01401-current","compilationNumber":null,"startDate":"2026-04-03","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Name","content":"#### 1 Name\n\n This instrument is the Medical Research Future Fund (Australian Medical Research and Innovation Priorities 2024-2026) Determination 2024.","sortOrder":0},{"sectionNumber":"2","sectionType":"section","heading":"Commencement","content":"#### 2 Commencement\n\n (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.\n\n```html\n

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1. The whole of this instrument

6 November 2024.

\n```\n\n> Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.\n\n (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.","sortOrder":1},{"sectionNumber":"3","sectionType":"section","heading":"Authority","content":"#### 3 Authority\n\n This instrument is made under subsection 32E(1) of the Medical Research Future Fund Act 2015.","sortOrder":2},{"sectionNumber":"4","sectionType":"section","heading":"Cessation","content":"#### 4 Cessation\n\n> Pursuant to subsection 32E(5) of the Medical Research Future Fund Act 2015 this instrument ceases at the end of two years beginning on the day the instrument commences.","sortOrder":3},{"sectionNumber":"5","sectionType":"section","heading":"Schedules","content":"#### 5 Schedules\n\n Schedule 1 to this instrument contains the Australian Medical Research and Innovation Priorities 2024-2026.\n\n \n\nSchedule 1—Australian Medical Research and Innovation Priorities 2024-2026","sortOrder":4}],"analysis":{"flash_summary_failed":{"failed":true,"reason":"Unauthenticated. Configure AI_GATEWAY_API_KEY or use a provider module. Learn more: https://ai-sdk.dev/unauthenticated-ai-gateway","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This instrument performs exactly the function intended by the parent Medical Research Future Fund Act 2015: setting biennial research priorities. The scope remains tightly constrained to declaring priority areas for funding allocation, with no expansion into operational or administrative matters."},"complexity_factors":["Extremely short instrument (5 sections plus schedule)","No defined terms section","Minimal cross-referencing (only references to parent Act for authority and cessation)","Straightforward commencement table with single date","Substantive content contained in Schedule 1, which appears to be a high-level policy document listing five priority areas rather than detailed operational rules","No conditional logic, exceptions, or nested provisions","Self-terminating after 2 years (sunset clause) with no complex renewal mechanisms"],"plain_english_summary":"This instrument sets Australia’s national priorities for allocating returns from the $20 billion Medical Research Future Fund for 2024–26, replacing the 2022–24 priorities and expiring in late 2026. \n\nIt directs MRFF funding toward five areas—consumer-centred care, clinical trials and registries, comparative effectiveness research, health services research, and capacity building—shaping grant decisions that affect researchers, universities, hospitals, the NHMRC, and ultimately patients by signalling which types of medical research the government will support."},"flash_summary":{"complexity_score":3,"scope_assessment":{"changed":false,"description":"The instrument operates within the power conferred by subsection 32E(1) of the Medical Research Future Fund Act 2015 and, as originally made, establishes time‑limited priorities (Schedule 1) for 2024–2026. The text identifies no deviation from that statutory scope and contains an explicit two‑year cessation (s 4), so there is no indication the scope has changed from the instrument’s original legal purpose."},"complexity_factors":["Short, focused instrument limited to naming and operational details rather than substantive regulatory regimes (ss 1–5).","Commencement specified by a formal table with an effective date (s 2) — procedural formality but low legal ambiguity.","Made under a cross‑reference to primary legislation (s 3: subsection 32E(1) of the Medical Research Future Fund Act 2015) — requires reading the Act to confirm legislative power and limits.","Automatic two‑year cessation (s 4: subsection 32E(5)) — temporary scope reduces long‑term complexity but requires timing management for renewals.","Substantive effect depends on Schedule 1 (s 5) which contains the actual priorities — the instrument’s practical complexity rests on the content of that Schedule rather than the instrument’s form.","Administrative discretion and funding consequences implied: priorities will guide MRFF allocation decisions, affecting applicants’ strategy and institutional planning (ss 3, 5).","Low compliance burden on the public as a rule‑setting instrument, but medium operational impact for grant applicants and administrators who must align proposals with the listed priorities."],"plain_english_summary":"This Determination sets the Australian Medical Research and Innovation Priorities for 2024–2026 that will guide how the Medical Research Future Fund directs funding. It commences on 6 November 2024 and ceases after two years.\n\nIt affects researchers, institutions and applicants by shaping which areas the MRFF prioritises for grants and investments. The instrument is made under subsection 32E(1) of the Medical Research Future Fund Act 2015 and contains its substantive priorities in Schedule 1."}},"importantCases":[],"_links":{"self":"/api/acts/medical-research-future-fund-australian-medical-research-and-innovation-priorities-2024-2026-determi","history":"/api/acts/medical-research-future-fund-australian-medical-research-and-innovation-priorities-2024-2026-determi/history","analysis":"/api/acts/medical-research-future-fund-australian-medical-research-and-innovation-priorities-2024-2026-determi/analysis","conflicts":"/api/acts/medical-research-future-fund-australian-medical-research-and-innovation-priorities-2024-2026-determi/conflicts","importantCases":"/api/acts/medical-research-future-fund-australian-medical-research-and-innovation-priorities-2024-2026-determi/important-cases","documents":"/api/acts/medical-research-future-fund-australian-medical-research-and-innovation-priorities-2024-2026-determi/documents"}}